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Abstract
Different approaches to enhance healing of hard or soft tissues include the use of cytokines 
and growth factors to modify cellular behaviour. Numerous growth factors are found in auto- 
logous blood concentrates – platelet-rich plasma (PRP) and platelet-rich fibrin (PRF). Enamel 
matrix derivative (EMD) may improve tissue healing via amelogenins. Bilayered collagen matrix 
(CM) is used for soft tissue augmentation.
The aim of the present study was to assess potential benefits of PRP, PRF and EMD in com-
bination with bilayered collagen matrix or CM alone in treatment of oral mucosal defects  
in rabbits.
Twenty-seven New Zealand white rabbits were included in this randomized controlled trial. 
Artificial oral mucosal defects were treated with one of these five approaches: PRP+CM, 
PRF+CM, EMD+CM, CM alone, or left untreated as a negative control - CO. The animals  
were euthanized 1 day, 7 days, or 28 days after surgery and necropsies were harvested. Histolo- 
gical and molecular biological analyses were performed.
All defects were healed by day 28. No differences between PRP+CM, PRF+CM, CM alone 
and CO groups were recorded at any time point. Slower angiogenesis and a higher presence  
of inflammatory infiltrate were observed in the EMD+CM group 28 days after surgery. Molecular 
biological analyses did not reveal any statistically significant changes.
In conclusion, no improvement in mucosal healing of wounds covered with a collagen mem-
brane and PRP, PRF, or EMD was observed, compared with CM alone or untreated controls.
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Introduction
Mucosal healing is in the centre of attention of perio- 
dontology, oral surgery, and implantology. Autogenous 
platelet concentrates such as platelet-rich plasma (PRP) 
and platelet-rich fibrin (PRF) are used to enhance muco-
sal and osseous healing via growth factors released 
from granules of the platelets, causing faster inflamma-
tory response and enhancement of healing process 
(Marx et al. 1998). Enamel matrix derivative (EMD; 
Emdogain®, Straumann AG, Switzerland) is also sup-
posed to influence scar formation and healing outcome. 
PRP, PRF or EMD are used in everyday practice of 
many dentists although the efficacy of these products 
has not been directly compared yet.
Growth factors (GFs) released from platelets’ alpha 
granules are able to promote fibroblast proliferation, 
increase tissue vascularity, and accelerate bone repair 
(Marx et al. 1998, Del Corso et al. 2012, Vokurka, 
Fassmann and Izakovičová Hollá 2015). Numerous 
platelet concentrates made from autologous blood 
have been developed in the past 20 years, but only 
limited attention has been paid to the comparison 
of their efficacy.
Platelet-rich plasma enhances healing of both bony 
and mucosal defects, especially in terms of leukocyte 
attraction, differentiation, and replication of stem cells 
(Dohan Ehrenfest 2010, Albanese et al. 2013). Never-
theless, a PRP has a strong stimulant effect on capillary 
regeneration in wound healing during the early stages 
of wound healing. (Lindeboom et al. 2007, Keskiner 
et al. 2014). Platelet-rich fibrin has been introduced 
as a second-generation product from autologous blood 
source (Moraschini and Barboza 2015, Miron and 
Choukroun 2017). Although it does not contain as high 
concentration of GFs compared to PRP, its ability 
to incorporate autologous GFs into a fibrin mesh 
is believed to boost the healing process (Davis et al. 
2014, Del Fabbro et al. 2014). Moreover, unlike PRP, 
it is cheap and easy to prepare.
Enhancement of healing has been described also 
for enamel proteins extracted from porcine foetuses, 
the main components of EMD. These proteins are able 
to accelerate formation of granulation tissue, induce 
proliferation of fibroblasts, or provoke production and 
release of growth factors (Bosshardt 2008). Currently, 
no study comparing EMD with blood plasma deriva-
tives in soft tissue healing is known to the authors.
Collagen matrix (CM) is used for augmentation 
of soft tissues in periodontology and implant dentistry. 
For regenerative procedures, CM is available as a dou-
ble layer porcine collagen membrane which enhances 
the soft tissues around both teeth and implants 
(Mucograft®, Geistlich AG, Switzerland). The capacity 
of CM as a carrier for autologous blood derivatives 
must be verified. 
The aim of the present study was to compare 
healing of artificial defects treated with PRP, PRF, and 
EMD together with collagen matrix or CM alone 
in a rabbit model.
Materials and Methods
Ethical statement
The experiment was performed in compliance with 
the Act No. 246/1992 of Collection of the Czech 
National Council on the protection of animals against 
cruelty, and with the agreement of the Branch Commi-
ssion for Animal Welfare of the Ministry of Agriculture 
of the Czech Republic.
The study was performed according to ARRIVE 
guidelines for reporting in vivo animal research 
(Kilkenny et al. 2010).
Study design
This study presents an animal experiment con- 
ducted in a split-mouth fashion, in the randomized com-
plete block design. Five defects were created in each 
of 27 animals. Then, every defect was assigned ran-
domly (upon drawing lots) to one of the five treatment 
options. Thus, a total of 135 sites were divided into 
5 groups. Before the interventions, the animals were 
randomly divided into 3 time-point groups according 
to the day of necropsy (Day 1, Day 7, Day 28). None 
of these details were known to the pathologist during 
the evaluation of harvested samples.
Animal model used
In the study, New Zealand white rabbits (Oryctola-
gus cuniculus), provided by a local accredited producer, 
were used. Prior to and during the experiment, 
the animals were housed under standard conditions 
at the Veterinary Research Institute (Brno, Czech 
Republic) and fed daily with no limitations. No adverse 
events occurred. All the animals thrived during the 
experimental period.
PRP preparation
Preparation protocol of PRP in our study was 
as follows: Ten millilitres of peripheral venous blood 
from vena auricularis was drained into a testing tube 
with 50 IU of heparin. The sample was centrifuged 
for 10 min with 400 g (centrifugal force) without brake 
at 21°C. Buffy coat and the superior layer of erythro-
cytes were collected and transferred into a new tube 
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and centrifuged for 10 min with 500 g at 21°C. After 
the centrifugation, 1.8 ml of PRP was obtained and 
immediately used during the surgery.
PRF preparation
For PRF preparation, 8 ml of peripheral venous 
blood was spun in a glass test tube with no added anti- 
coagulant in a PC02 centrifuge (Process, Nice, France) 
for 14 minutes at 1500 rpm. The PRF clot was then 
removed from the tube and inserted into a PRF box 
for further use. 
Intervention
Rabbits were anaesthetized with propofol 8-15 mg/kg 
IV for surgical creation of five artificial round defects 
with a diameter of 5 mm in the maxillary region using 
a mucotome and a 15C blade. The defects were filled 
either with CM alone, CM with PRP, CM with PRF, 
CM with EMD, or left untreated as the negative control 
(CO). The animals were divided randomly into three 
groups. The first group was sacrificed 1 day after sur-
gery, the second after 7 days, and the third after 28 days. 
Subsequently, necropsies from the studied region were 
harvested and preserved for histological, immunohisto-
chemical and molecular biological analysis.
Histopathological assessment
For light microscopy, the samples were dyed 
with haematoxylin and eosin (H&E) staining. Special 
staining Masson’s trichrome was used for the detection 
of collagen fibres. The specimens were evaluated 
at magnification of x400. New vessels and macrophages 
were counted in the specific area. In the specimens, 
the macrophages were detected immunohistochemically 
by use of Monoclonal Mouse Anti-Rabbit Macrophage 
Clone RAM11, isotope IgG1 (DAKO, Glostrup, 
Denmark). The pathologist rated semiquantitatively 
according to Table 1.
Molecular biological assessment
Samples for molecular biological analyses were 
lysed in TRI Reagent RT (Molecular Research Centre, 
Cincinnati, OH, United States). Total RNA with elution 
volume of 15 μl was obtained using the combination 
of 4-bromoanisole phase separation followed by silica- 
-based RNeasy purification (Qiagen, Hilden, Germa-
ny). mRNA was specifically reverse-transcribed using 
M-MLV reverse transcriptase system (Invitrogen, 
Paisley, UK) in the presence of oligo-dT primer. cDNA 
was diluted 5x and 0.5 μl used in qPCR. In qPCR 
analysis, RNA expression was quantified in triplicate 
reactions in a final volume of 3 μl in 384-well plates 
using QuantiTect SYBR Green PCR master mix 
(Qiagen, Hilden, Germany) following the manufac- 
turer’s recommendations. qPCR reactions were pre-
pared with the assistance of Nanodrop II liquid dispen- 
ser (Innovadyne Technologies, Rohnert Park, CA, 
United States). qPCR was performed under the follow-
ing conditions: denaturation (95°C for 15 min) and 
45 amplification cycles (95°C for 15 s, 58°C for 30 s 
and 72°C for 30 s). Resulting melting curves were 
analysed to test the product specificity. Each couple 
of primers (Generi Biotech, Hradec Kralove, Czech 
Republic) at 10 pmol was used per reaction. Primers 
specific to eight target genes, coding for cytokines with 
pro- and anti-inflammatory properties, and three refe- 
rence genes (Table 2) were used for simultaneous 
measurements of gene expression activity. From the ob-
tained data, relative expression of each target gene was 
calculated according to the formula [1/(2target gene 
Ct)]/[1/(2reference gene Ct)].
Statistical analysis
The sample size calculation in this exploratory 
experiment was based on the “resource equation” 
(Mead 1988). With nine animals and five defects/inter-
ventions each, designed in nine blocks, we got error 
degrees of freedom = 33 for each of the three time 
points (calculated for ANOVA test). Although this num-
Table 1. Scoring system according to Abramov (2007). The scheme used for a semiquantitative evaluation of re-epithelialization, 
level of angiogenesis, the presence of granulation tissue, quantity of collagen and macrophages, acute and chronic inflammatory infiltrate.
















0 0 0 (no fibroblasts) 0 0-12 1a 0 0
1 (partial) 1 (>5 vessels/HPF) 1 (few fibroblasts) 1 13-25 1b 1 1
2 (complete, but immature or thin) 2 (6-10 vessels/HPF) 2 (more fibroblasts) 2 26-37 2a 2 2
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ber exceeds an expected optimum of less than 20 error 
degrees of freedom, we considered this number 
at the beginning of the experiment. Thus, we avoided 
imbalances and less efficient statistics with ordinal 
(histopathologic scores) data caused by potential drop-
outs during the experiment.
Molecular biological data was logarithmically 
transformed to achieve an approximately normal distri-
bution. The treatment groups were compared using 
ANOVA test with an adjustment for complete block 
design, the comparison was performed separately for 
each time point (TP1, TP7). The data was summarized 
in plots as means with standard errors for the respective 
groups with accompanying statistical data.
ANOVA was used for the evaluation of histopatho-
logical score data summarized for each time point 
(TP1, TP7, TP28) using bar plots. The significance 
level alpha equalled to 0.05. The analyses were per-
formed using SAS 9.3. and R (R Core Team 2019).
Results
Histopathological observation
At day 1 (Fig. 1), histological observation revealed 
an early defect with the presence of œdema, necrotic 
debris, haemorrhages, fibrin, and dense acute inflam-
matory infiltrate with a predominance of neutrophil 
granulocytes. The wounds were without signs of 
re-epithelialization. At day 7 (Fig. 2), proliferating 
granulation tissue filling the empty space after phago-
cytosis of necrotic tissue was detected around the 
defect. A mixed, predominantly acute inflammatory 
cellularization with a high number of neutrophil granu-
locytes and sporadic lymphocytes was present. 
An incipient re-epithelialization at wound margins 
was occasionally seen. At day 28 (Fig. 3), com-
plete re-epithelialization of the wound was observed, 
the wound was overlaid with a focally immature 
squamous epithelium. A scar and chronic inflammatory 
Table 2. Primers used for molecular biologic assessment of inflammatory response.
Gene Primer sequence (3´- 5´) Function
IL-1β
F: ACCAACAAGTGGTGTTCTCCATGA




Tumor necrosis factor α, pro-inflammatory cytokine
R: AGGTTGTTTGGGGACTGCTCT
IL-17
F: ACCACATGAACTCTGTCCCAATC Interleukin 17, proinflammatory cytokine, chemokine, 
production of antibacterial peptidesR: CCTACAGCCACCAGCATCTTC
MMP9
F: CACTGGGCTTGGATCACTCCTC Matrix metalloproteinase 9, proinflammatory mediator, 
destruction of tissueR: GGGTTAGGACCATATAGATGCTGGA
IL-10
F: TTCTGTGCCTGACCACACTTTC




Transforming growth factor β, antiinflammatory cytokine
R: CACTCTGGCTTTTGGGTTCTGC
VEGF
F: GCTTCTTGTCTCTGGCGTGTTC Vascular endothelial growth factor, antiinflammatory 
cytokine, vascularizationR: CCTACATAAGCCTTGGCCTCCTC
TIMP1
F: GTTTCTCATCGCTGGACAACTGC Tissue inhibitor of metalloproteinases, antiinflammatory 
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infiltrate with lymphocytes and plasmocytes are filling 
the defect.
Although changes of histopathological parameters 
were easily noticeable at all time points (Fig. 4), 
no statistically significant differences between the study 
groups were found. Higher mean scores of angiogenesis 
and chronic inflammatory infiltrate were recorded only 
in the EMD group at day 28. 
Molecular biological assessment
Similar to the results of the histopathological exami- 
nation, the results of molecular biological analyses did 
not reveal any statistically significant changes among 
the treatments (Fig. 5).
Discussion
Many studies have confirmed the advantages 
of the use of PRP or PRF for the treatment of periodon-
tal defects, single and multiple gingival recession, 
periimplantitis, medication-related osteonecrosis of jaws, 
and various other conditions (Del Fabbro et al. 2014, 
Del Fabbro et al. 2015a,b).
Some studies have shown positive effect of PRP and 
PRF during early stages of healing (Lindeboom et al. 
2007, Suttapreyasri and Leepong 2013) whilst others 
have not confirmed such conclusions (Jankovic et al. 
2012, Keskiner et al. 2014). Our study did not confirm 
the improved efficiency of PRP or PRF with CM com-
pared to CM without blood plasma derivatives.
Both PRP and PRF have also been tested for their 
content of vascular endothelial growth factor (VEGF) 
prepared from rabbit blood (Vokurka et al. 2016). 
In this study, VEGF was found at lower concentrations 
in PRF compared to PRP, other parameters did not 
differ.
Molecular biology did not show any relevant diffe- 
rences either. Only regarding vascularization, higher 
mean scores of angiogenesis were noted in the EMD 
group at day 28. It may be since the expression 
of mRNA for TIMP was the lowest, unfortunately with-
out statistical significance, in the EMD group at day 7. 
In a rat model, Miron et al. (2014) observed signifi- 
cantly increased angiogenesis in the early phases 
of tissue regeneration in the animals treated with EMD. 
Our study showed opposite results with a slight non- 
-significant negative effect of EMD on early phases 
of angiogenesis. 
Collagen matrix was proved in augmentation 
of the volume of keratinized gingiva (Sanz et al. 2009) 
compared to connective tissue graft. Our results did 
not prove any additional benefit of PRP, PRF, or EMD 
together with CM in terms of soft tissue healing. 
Fig. 3. Artificial defect, day 28. Complete re-epithelialisation 
of the wound, subepithelial granulation tissue transformed into 
the scar with a dense network of collagen fibres (H&E, x40).
Fig. 1. Artificial defect, day 1. Defect with the presence 
of a dense acute inflammatory infiltrate with a predominance 
of granulocytes, filled with erythrocytes, neutrophil granulocytes 
and necrotic debris [haematoxylin-eosin staining (H&E), x200].
Fig. 2. Artificial defect, day 7. Defect with noticeable incipient 
re-epithelialization, filled with inflammatory infiltrated granula-
tion tissue and covered with cell debris (H&E, x200).
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Conclusion
The positive effect of blood plasma derivatives 
(PRP or PRF) and EMD added to the collagen matrix 
was studied. This experimental study did not confirm 
any significant improvement of soft tissue healing when 
applying combination of CM with PRP, PRF, or EMD 
compared with CM alone or untreated controls.
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Fig. 4. Histopathological parameters. Presentation of statistical analysis of individual parameters at day 1 (Time 1), day 7 (Time 2) and 
day 28 (Time 3). (A) re-epithelialisation, (B) angiogenesis, (C) granulation, (D) collagen fibres, (E) macrophages, (F) acute inflammatory 
infiltrate and (G) chronic inflammatory infiltrate.
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